0001209191-19-025629.txt : 20190423 0001209191-19-025629.hdr.sgml : 20190423 20190423191216 ACCESSION NUMBER: 0001209191-19-025629 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180305 FILED AS OF DATE: 20190423 DATE AS OF CHANGE: 20190423 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Motahari Saeed CENTRAL INDEX KEY: 0001704399 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35902 FILM NUMBER: 19762390 MAIL ADDRESS: STREET 1: C/O INSYS THERAPEUTICS, INC. STREET 2: 1333 SOUTH SPECTRUM BLVD, SUITE 100 CITY: CHANDLER STATE: AZ ZIP: 85286 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Insys Therapeutics, Inc. CENTRAL INDEX KEY: 0001516479 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 510327886 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10220 SOUTH 51ST STREET STREET 2: SUITE 2 CITY: PHOENIX STATE: AZ ZIP: 85044 BUSINESS PHONE: 602-910-2617 MAIL ADDRESS: STREET 1: 10220 SOUTH 51ST STREET STREET 2: SUITE 2 CITY: PHOENIX STATE: AZ ZIP: 85044 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-03-05 0 0001516479 Insys Therapeutics, Inc. INSY 0001704399 Motahari Saeed C/O INSYS THERAPEUTICS, INC. 1333 SOUTH SPECTRUM BLVD, SUITE 100 CHANDLER AZ 85286 1 1 0 0 President & CEO Common Stock 2018-03-05 4 A 0 16000 0.00 A 70986 D Common Stock 2019-01-25 4 A 0 59206 0.00 A 130192 D Employee Stock Option (right to buy) 8.06 2018-03-05 4 A 0 64000 0.00 A 2028-03-04 Common Stock 64000 64000 D Employee Stock Option (right to buy) 3.81 2019-01-25 4 A 0 282152 0.00 A 2029-01-24 Common Stock 282152 282152 D The total reported in Column 5 includes 33,000 RSUs previously reported in Table II on the Form 4 filed 4/20/17. Also includes 2,283 and 4,303 shares acquired by the Reporting Person on 12/8/17 and 6/8/18, respectively, pursuant to the Issuer's Employer Stock Purchase Plan. The option vests in 48 equal monthly installments and will be fully vested and exercisable on March 5, 2022. The option vests in 48 equal monthly installments and will be fully vested and exercisable on January 25, 2023. /s/ Andrew Long, Attorney-in-fact 2019-04-19